By contrast, an immune suppressive alternative activity of the RANKL/RANK axis in TME has been described because RANKL induces activation of RANK on melanoma-associated DCs thus exerting a tolerogenic effect (129). This evidence concerns the gene TNFRSF11A and melanoma.